150 related articles for article (PubMed ID: 10533579)
1. Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation.
Gaspo R; Sun H; Fareh S; Levi M; Yue L; Allen BG; Hebert TE; Nattel S
Cardiovasc Res; 1999 May; 42(2):434-42. PubMed ID: 10533579
[TBL] [Abstract][Full Text] [Related]
2. Changes in L-type calcium channel abundance and function during the transition to pacing-induced congestive heart failure.
Mukherjee R; Hewett KW; Walker JD; Basler CG; Spinale FG
Cardiovasc Res; 1998 Feb; 37(2):432-44. PubMed ID: 9614498
[TBL] [Abstract][Full Text] [Related]
3. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation.
Yue L; Feng J; Gaspo R; Li GR; Wang Z; Nattel S
Circ Res; 1997 Oct; 81(4):512-25. PubMed ID: 9314832
[TBL] [Abstract][Full Text] [Related]
4. Relationship between beta-adrenoceptors and calcium channels in human ventricular myocardium.
Ferry DR; Kaumann AJ
Br J Pharmacol; 1987 Mar; 90(3):447-57. PubMed ID: 2436700
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups.
Murphy BJ; Washkurak AW; Tuana BS
Biochim Biophys Acta; 1990 May; 1052(2):333-9. PubMed ID: 2159349
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation.
Yue L; Melnyk P; Gaspo R; Wang Z; Nattel S
Circ Res; 1999 Apr; 84(7):776-84. PubMed ID: 10205145
[TBL] [Abstract][Full Text] [Related]
7. Identification of dihydropyridine (DHP) binding sites on cultured monkey renal cells (GMRC) with a photoaffinity probe (-)-[3H]-azidopine.
Drímal J
Gen Physiol Biophys; 1994 Apr; 13(2):137-48. PubMed ID: 7528701
[TBL] [Abstract][Full Text] [Related]
8. Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation.
Gaspo R; Bosch RF; Bou-Abboud E; Nattel S
Circ Res; 1997 Dec; 81(6):1045-52. PubMed ID: 9400386
[TBL] [Abstract][Full Text] [Related]
9. The beta-adrenergic receptor-regulated 1,4-dihydropyridine calcium channel receptor sites in coronary artery smooth muscle.
Drímal J
Physiol Res; 1991; 40(5):481-91. PubMed ID: 1725962
[TBL] [Abstract][Full Text] [Related]
10. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs.
Fareh S; Bénardeau A; Nattel S
Cardiovasc Res; 2001 Mar; 49(4):762-70. PubMed ID: 11230975
[TBL] [Abstract][Full Text] [Related]
11. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
Rasmussen RP; Minobe W; Bristow MR
Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
[TBL] [Abstract][Full Text] [Related]
12. Atrial L-type Ca2+-channel, beta-adrenorecptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation.
Grammer JB; Zeng X; Bosch RF; Kühlkamp V
Basic Res Cardiol; 2001 Feb; 96(1):82-90. PubMed ID: 11215536
[TBL] [Abstract][Full Text] [Related]
13. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia.
Sun H; Gaspo R; Leblanc N; Nattel S
Circulation; 1998 Aug; 98(7):719-27. PubMed ID: 9715865
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 1,4-dihydropyridine and beta-adrenergic receptor sites in coronary artery smooth muscle membranes.
Drimal J
Cell Signal; 1991; 3(3):225-32. PubMed ID: 1716451
[TBL] [Abstract][Full Text] [Related]
15. The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs.
Fareh S; Bénardeau A; Thibault B; Nattel S
Circulation; 1999 Nov; 100(21):2191-7. PubMed ID: 10571979
[TBL] [Abstract][Full Text] [Related]
16. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model.
Gaspo R; Bosch RF; Talajic M; Nattel S
Circulation; 1997 Dec; 96(11):4027-35. PubMed ID: 9403628
[TBL] [Abstract][Full Text] [Related]
17. The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes.
Guerra L; Cerbai E; Gessi S; Borea PA; Mugelli A
Br J Pharmacol; 1996 Jul; 118(5):1278-84. PubMed ID: 8818354
[TBL] [Abstract][Full Text] [Related]
18. Dihydropyridine binding and Ca(2+)-channel characterization in clonal calcitonin-secreting cells.
Krautwurst D; Scherübl H; Kleppisch T; Hescheler J; Schultz G
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):659-65. PubMed ID: 8382045
[TBL] [Abstract][Full Text] [Related]
19. Developmental changes in beta-adrenoceptors, muscarinic cholinoceptors and Ca2+ channels in rat ventricular muscles.
Kojima M; Ishima T; Taniguchi N; Kimura K; Sada H; Sperelakis N
Br J Pharmacol; 1990 Feb; 99(2):334-9. PubMed ID: 2158375
[TBL] [Abstract][Full Text] [Related]
20. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
